CN1917856A - 口服皮肤保湿剂及功能食品和饮料 - Google Patents
口服皮肤保湿剂及功能食品和饮料 Download PDFInfo
- Publication number
- CN1917856A CN1917856A CNA2004800416948A CN200480041694A CN1917856A CN 1917856 A CN1917856 A CN 1917856A CN A2004800416948 A CNA2004800416948 A CN A2004800416948A CN 200480041694 A CN200480041694 A CN 200480041694A CN 1917856 A CN1917856 A CN 1917856A
- Authority
- CN
- China
- Prior art keywords
- skin
- milk
- fermented whey
- beverage
- functional food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013376 functional food Nutrition 0.000 title claims abstract description 24
- 239000005862 Whey Substances 0.000 claims abstract description 58
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 58
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 58
- 235000013336 milk Nutrition 0.000 claims abstract description 34
- 239000008267 milk Substances 0.000 claims abstract description 34
- 210000004080 milk Anatomy 0.000 claims abstract description 34
- 230000000694 effects Effects 0.000 claims abstract description 29
- 240000002605 Lactobacillus helveticus Species 0.000 claims abstract description 21
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims abstract description 21
- 229940054346 lactobacillus helveticus Drugs 0.000 claims abstract description 20
- 235000013361 beverage Nutrition 0.000 claims description 26
- 238000000855 fermentation Methods 0.000 claims description 18
- 230000004151 fermentation Effects 0.000 claims description 18
- 239000004909 Moisturizer Substances 0.000 claims description 14
- 230000001333 moisturizer Effects 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 235000020510 functional beverage Nutrition 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000003020 moisturizing effect Effects 0.000 abstract description 9
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000015140 cultured milk Nutrition 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 28
- 239000000523 sample Substances 0.000 description 19
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 210000002615 epidermis Anatomy 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 13
- 239000006071 cream Substances 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 10
- 235000014655 lactic acid Nutrition 0.000 description 9
- 239000004310 lactic acid Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000000835 fiber Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000000080 wetting agent Substances 0.000 description 8
- 102000015785 Serine C-Palmitoyltransferase Human genes 0.000 description 7
- 108010024814 Serine C-palmitoyltransferase Proteins 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 5
- 230000037336 dry skin Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 230000037311 normal skin Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000001493 Cyclophilins Human genes 0.000 description 2
- 108010068682 Cyclophilins Proteins 0.000 description 2
- 229930182843 D-Lactic acid Natural products 0.000 description 2
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 229930064664 L-arginine Natural products 0.000 description 2
- 235000014852 L-arginine Nutrition 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000020244 animal milk Nutrition 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004508 fractional distillation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 101150028074 2 gene Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000709480 Diaphanes Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 101710089384 Extracellular protease Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108020005004 Guide RNA Proteins 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 125000001549 ceramide group Chemical group 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 235000014048 cultured milk product Nutrition 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 235000021001 fermented dairy product Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000020252 horse milk Nutrition 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 235000020122 reconstituted milk Nutrition 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 108010078692 yeast proteinase B Proteins 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
- A23C21/026—Whey; Whey preparations containing, or treated with, microorganisms or enzymes containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/986—Milk; Derivatives thereof, e.g. butter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
Description
浓度(v/v%) | 对正常人表皮细胞SPTmRNA的影响 | 对正常人表皮细胞纤维聚合蛋白mRNA的影响 | |||
第一次测试 | 第二次测试 | 第一次测试 | 第二次测试 | ||
对照标准 | 0 | 100 | 100 | 100 | 100 |
对比样品1乳酸水溶液(a) | 0.63 | 91 | 111 | 15 | 132 |
1.25 | 84 | 129 | 87 | 116 | |
样品1发酵乳清(A) | 0.63 | 153 | 171 | 509 | 196 |
1.25 | 156 | 154 | 543 | 168 |
基因 | 序列 | PCR条件 | ||
温度(℃) | 周期 | |||
SPT | 正义反义 | 5’-GAG GCT CAC AGC ATT GGC GC-3’5’-GGC CTG TCC AGT AGA GGT AC-3’ | 58 | 30 |
纤维聚合蛋白 | 正义反义 | 5’-CAA GCA GAG AAA CAC GTA ATG AGG-3’5’-CGC ACT TGC TTT ACA GAT ATC AGA-3’ | 56 | 30 |
cyclo-philin | 正义反义 | 5’-CCG GGT GAT CTT TGG-3’5’-GGC GAT GGC AAA GGG-3’ | 58 | 30 |
服用前 | 服用三周后 | |
平均值±标准偏差 | 平均值±标准偏差 | |
含发酵乳清(A)的饮料(样品1) | 128.8±56.4 | 90.3±76.7 |
含未发酵乳清的饮料(对比样品2) | 117.5±87.7 | 53.6±35.5 |
服用前 | 服用三周后 | ||
平均值±标准偏差 | 平均值±标准偏差 | ||
含发酵乳清(A)的饮料(样品1) | 干燥皮肤 | 82.8±30.2 | 85.3±86.6 |
正常皮肤 | 169.0±40.1 | 94.8±72.7 | |
含未发酵乳清(A)的饮料(对比样品2) | 干燥皮肤 | 69.4±41.9 | 48.0±28.1 |
正常皮肤 | 197.7±87.0 | 62.9±46.8 |
使用前 | 使用三周后 | |
平均值±标准偏差 | 平均值±标准偏差 | |
含乳清(A)的乳霜 | 142.1±100.3 | 72.4±59.5 |
对比乳霜 | 144.9±97.6 | 77.8±46.9 |
Claims (5)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003429243 | 2003-12-25 | ||
JP429243/2003 | 2003-12-25 | ||
JP322587/2004 | 2004-11-05 | ||
JP2004322587A JP4680571B2 (ja) | 2003-12-25 | 2004-11-05 | 経口摂取用保湿剤 |
PCT/JP2004/019330 WO2005063196A1 (ja) | 2003-12-25 | 2004-12-24 | 経口摂取用皮膚保湿剤及び機能性飲食品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1917856A true CN1917856A (zh) | 2007-02-21 |
CN1917856B CN1917856B (zh) | 2010-06-16 |
Family
ID=34742108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2004800416948A Expired - Fee Related CN1917856B (zh) | 2003-12-25 | 2004-12-24 | 口服皮肤保湿剂及功能食品和饮料 |
Country Status (15)
Country | Link |
---|---|
US (2) | US20070122454A1 (zh) |
EP (1) | EP1698320B1 (zh) |
JP (1) | JP4680571B2 (zh) |
KR (1) | KR101110862B1 (zh) |
CN (1) | CN1917856B (zh) |
AT (1) | ATE497758T1 (zh) |
AU (1) | AU2004308816C1 (zh) |
BR (1) | BRPI0418176A (zh) |
CA (1) | CA2549703A1 (zh) |
DE (1) | DE602004031365D1 (zh) |
DK (1) | DK1698320T3 (zh) |
MX (1) | MXPA06007083A (zh) |
PT (1) | PT1698320E (zh) |
RU (1) | RU2369378C2 (zh) |
WO (1) | WO2005063196A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103025338A (zh) * | 2010-05-21 | 2013-04-03 | 株式会社明治 | 用于改善皮肤状态的组合物 |
CN107072916A (zh) * | 2014-11-10 | 2017-08-18 | 昭和电工株式会社 | 保湿剂 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2006095764A1 (ja) * | 2005-03-09 | 2008-08-14 | カルピス株式会社 | 皮膚における紫外線感受性抑制剤及び機能性飲食品 |
EP1902720B1 (en) * | 2005-06-24 | 2014-09-17 | Calpis Co., Ltd. | Fermented milk whey for an oral use in improving symptoms of atopic dermatitis, xeroderma or psoriasis. |
JP5198865B2 (ja) * | 2005-08-26 | 2013-05-15 | カルピス株式会社 | 筋肉痛抑制剤 |
JP5274814B2 (ja) | 2007-03-13 | 2013-08-28 | 雪印メグミルク株式会社 | 美白剤 |
TW201028171A (en) | 2008-12-15 | 2010-08-01 | Calpis Co Ltd | Peptides for inhibiting skin aging |
WO2012002322A1 (ja) | 2010-06-28 | 2012-01-05 | 株式会社ヤクルト本社 | 経口用皮膚性状改善剤 |
US9913799B2 (en) | 2014-07-11 | 2018-03-13 | Mary Kay Inc. | Cosmetic compositions and methods of their use |
WO2019158652A1 (fr) * | 2018-02-14 | 2019-08-22 | Danstar Ferment Ag | Composition cosmetique ou dermatologique et methode pour l'hydratation cutanee |
KR101974405B1 (ko) | 2018-11-30 | 2019-05-02 | 이호 | 초유 유청 단백질 가수분해물을 유효성분으로 포함하는 피부 재생용 화장료 조성물 |
KR102389105B1 (ko) | 2020-06-17 | 2022-05-06 | 마루온 주식회사 | 파인애플 유래 세라마이드를 유효성분으로 포함하는 식품 조성물 및 그 제조방법 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR800001462B1 (ko) * | 1979-05-01 | 1980-12-10 | 강원명 | 탈지유로부터 화장품 원료를 제조하는 방법 |
US5656268A (en) * | 1995-04-21 | 1997-08-12 | Sorodsky; Michael | Biological product |
US5854029A (en) * | 1996-08-02 | 1998-12-29 | Calpis Co., Ltd. | Method for preparing antihypertensive agent |
JP4065038B2 (ja) * | 1996-08-07 | 2008-03-19 | カルピス株式会社 | 計算作業負荷ストレス緩和剤 |
JP3028411B2 (ja) * | 1997-09-26 | 2000-04-04 | カルピス株式会社 | トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌 |
BR9907944A (pt) * | 1998-03-16 | 2000-10-24 | Procter & Gamble | Processos para adsorver água ou para absorver água na pele de um mamìfero, para umedecimento ou hidratação da pele de um mamìfero e artigo de manufatura |
FR2778565B1 (fr) * | 1998-05-14 | 2000-07-28 | Silab Sa | Procede d'extraction de principes actifs vegetaux a partir de graines de lupin blanc doux, extrait obtenu et composition utilisant au moins une fraction de cet extrait |
EP1142481B2 (en) * | 1999-01-11 | 2009-09-02 | Calpis Co., Ltd. | Process for producing fermented milk containing angiotensin converting enzyme inhibitory peptide and process for producing milk serum |
JP2000239175A (ja) * | 1999-02-18 | 2000-09-05 | Calpis Co Ltd | 抗アレルギー剤 |
JP2001031557A (ja) | 1999-07-23 | 2001-02-06 | Health Guide:Kk | 聖徳石含有化粧料組成物 |
JP2001163799A (ja) * | 1999-12-08 | 2001-06-19 | Miyagi Kagaku Kogyo Kk | 低抗原性保湿剤、低抗原性外用剤および低抗原性飲料 |
JP2002241289A (ja) * | 2001-02-16 | 2002-08-28 | Ichimaru Pharcos Co Ltd | 肥厚化角質層柔軟化剤 |
JP4813690B2 (ja) * | 2001-06-05 | 2011-11-09 | 丸善製薬株式会社 | フィラグリン合成促進剤、角質層保湿機能改善・増強剤および角質層遊離アミノ酸量増加剤 |
JP2003081868A (ja) * | 2001-09-12 | 2003-03-19 | Ichimaru Pharcos Co Ltd | ストレス抑制剤 |
JP2003135026A (ja) * | 2001-11-06 | 2003-05-13 | Sunstar Inc | 保湿用食品 |
JP2003146886A (ja) * | 2001-11-14 | 2003-05-21 | Noevir Co Ltd | フィラグリン合成促進剤、及び角質層保湿機能改善剤,角質層柔軟化剤,角質層遊離アミノ酸増加剤 |
-
2004
- 2004-11-05 JP JP2004322587A patent/JP4680571B2/ja active Active
- 2004-12-24 DE DE602004031365T patent/DE602004031365D1/de active Active
- 2004-12-24 BR BRPI0418176-0A patent/BRPI0418176A/pt not_active Application Discontinuation
- 2004-12-24 EP EP04807687A patent/EP1698320B1/en active Active
- 2004-12-24 PT PT04807687T patent/PT1698320E/pt unknown
- 2004-12-24 AU AU2004308816A patent/AU2004308816C1/en not_active Ceased
- 2004-12-24 KR KR1020067012607A patent/KR101110862B1/ko not_active IP Right Cessation
- 2004-12-24 DK DK04807687.1T patent/DK1698320T3/da active
- 2004-12-24 CA CA002549703A patent/CA2549703A1/en not_active Abandoned
- 2004-12-24 US US10/596,753 patent/US20070122454A1/en not_active Abandoned
- 2004-12-24 RU RU2006126980/15A patent/RU2369378C2/ru not_active IP Right Cessation
- 2004-12-24 CN CN2004800416948A patent/CN1917856B/zh not_active Expired - Fee Related
- 2004-12-24 AT AT04807687T patent/ATE497758T1/de not_active IP Right Cessation
- 2004-12-24 WO PCT/JP2004/019330 patent/WO2005063196A1/ja active Application Filing
- 2004-12-24 MX MXPA06007083A patent/MXPA06007083A/es active IP Right Grant
-
2010
- 2010-02-24 US US12/711,451 patent/US20100151039A1/en not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103025338A (zh) * | 2010-05-21 | 2013-04-03 | 株式会社明治 | 用于改善皮肤状态的组合物 |
CN103025338B (zh) * | 2010-05-21 | 2015-01-28 | 株式会社明治 | 用于改善皮肤状态的组合物 |
CN107072916A (zh) * | 2014-11-10 | 2017-08-18 | 昭和电工株式会社 | 保湿剂 |
Also Published As
Publication number | Publication date |
---|---|
MXPA06007083A (es) | 2006-08-23 |
DE602004031365D1 (de) | 2011-03-24 |
EP1698320A1 (en) | 2006-09-06 |
RU2006126980A (ru) | 2008-01-27 |
AU2004308816A1 (en) | 2005-07-14 |
CN1917856B (zh) | 2010-06-16 |
CA2549703A1 (en) | 2005-07-14 |
US20070122454A1 (en) | 2007-05-31 |
AU2004308816C1 (en) | 2011-02-10 |
AU2004308816B2 (en) | 2010-08-26 |
PT1698320E (pt) | 2011-05-09 |
US20100151039A1 (en) | 2010-06-17 |
EP1698320A4 (en) | 2009-02-18 |
RU2369378C2 (ru) | 2009-10-10 |
JP4680571B2 (ja) | 2011-05-11 |
KR101110862B1 (ko) | 2012-02-15 |
WO2005063196A1 (ja) | 2005-07-14 |
KR20060121240A (ko) | 2006-11-28 |
EP1698320B1 (en) | 2011-02-09 |
DK1698320T3 (da) | 2011-03-14 |
ATE497758T1 (de) | 2011-02-15 |
JP2005206578A (ja) | 2005-08-04 |
BRPI0418176A (pt) | 2007-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1271936C (zh) | 共生功能性食品 | |
CN1126814C (zh) | 用嗜热链球菌制备富含半乳糖-低聚糖和β-半乳糖苷酶的发酵产品 | |
JP4198728B2 (ja) | 動物用免疫活性調整剤、及びその調整剤を含有する動物用飼料 | |
Hillal et al. | Effect of growth promoters (probiotics) supplementation on performance, rumen activity and some blood constituents in growing lambs | |
CN1917856A (zh) | 口服皮肤保湿剂及功能食品和饮料 | |
EP2828375B1 (en) | Gaba-producing culturable bacteria derived from the human gastrointestinal tract | |
JP2010095465A (ja) | 乳酸菌含有免疫賦活用組成物 | |
CN1157221C (zh) | 保健组合物 | |
Belal et al. | Use of spirulina (Arthrospira fusiformis) for promoting growth of Nile Tilapia fingerlings | |
CN1678330A (zh) | 抗***反应剂及其在减弱***反应中的用途和减弱***反应的方法 | |
EP2532351A1 (en) | Agent for improving motility function | |
EP1902720B1 (en) | Fermented milk whey for an oral use in improving symptoms of atopic dermatitis, xeroderma or psoriasis. | |
CN102618452A (zh) | 唾液乳杆菌及其代谢物的制备方法和组合物以及应用 | |
EP2517715B1 (en) | Composition containing propionic acid bacteria for use in preventing and/or treating acidosis | |
JP5855375B2 (ja) | 抗疲労組成物 | |
JP5192108B2 (ja) | 反芻動物用のメタン生成抑制用組成物及び飼料用組成物 | |
CN1911053A (zh) | 降血糖的酸奶 | |
JP5801344B2 (ja) | 反芻動物の反芻胃内のメタン生成抑制能を有する微生物及びその利用 | |
EP2893815A1 (en) | Assorted livestock feed with enhanced nutrients and method of preparing the same | |
CN1502251A (zh) | 一种复合菌型乳制品及其制备方法 | |
US20200246400A1 (en) | Growth-stimulating lactobacillus strains | |
KR20150089266A (ko) | 템페 균주 및 바실러스 속 균주를 이용한 고상발효에 의한 항균 활성을 가지는 가축용 사료첨가제의 제조방법 및 그에 따른 사료첨가제 | |
CN114209049A (zh) | 一种海洋益生元组合物及其制备方法和用途 | |
WO2007023896A1 (ja) | 筋肉痛抑制剤及び筋肉痛抑制用機能性食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160324 Address after: Tokyo, Japan Patentee after: ASAHI CALPIS WELLNESS Co.,Ltd. Address before: Tokyo, Japan Patentee before: CALPIS Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Tokyo, Japan Patentee after: Asahi bio Recycling Technology Co.,Ltd. Address before: Tokyo, Japan Patentee before: ASAHI CALPIS WELLNESS Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200911 Address after: Tokyo, Japan Patentee after: ASAHI CALPIS WELLNESS Co.,Ltd. Address before: Tokyo, Japan Patentee before: Asahi bio Recycling Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: Tokyo, Japan Patentee after: Asahi bio Recycling Technology Co.,Ltd. Address before: Tokyo, Japan Patentee before: ASAHI CALPIS WELLNESS Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201009 Address after: Tokyo, Japan Patentee after: ASAHI CALPIS WELLNESS Co.,Ltd. Address before: Tokyo, Japan Patentee before: Asahi bio Recycling Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210604 Address after: Tokyo, Japan Patentee after: ASAHI GROUP FOODS, Ltd. Address before: Tokyo, Japan Patentee before: ASAHI CALPIS WELLNESS Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100616 |
|
CF01 | Termination of patent right due to non-payment of annual fee |